Top Markets
Coin of the day
NuCana plc NuCana plc

NuCana plc

NCNA
Rank in Stocks #32729
NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering... NuCana plc is a clinical-stage biopharmaceutical firm dedicated to pioneering advanced therapies for oncology. Its innovative product pipeline is underpinned by a proprietary ProTide technology platform. Among its key drug candidates, Acelarin is progressing through multiple clinical evaluations: a Phase I study for advanced solid tumors, Phase Ib trials for both recurrent ovarian cancer and biliary tract cancer, a Phase II trial targeting platinum-resistant ovarian cancer, and a pivotal Phase III trial for pancreatic cancer. NuCana is also developing NUC-3373, a ProTide derivative of 5-fluorouracil’s active anti-cancer metabolite. This compound is currently in a Phase I study for advanced solid tumors and a Phase Ib/2 trial for advanced colorectal cancer. Additionally, NUC-7738, a nucleoside analog, is undergoing Phase 1/2 clinical assessment for both advanced solid and hematological malignancies. To support its ProTide technology development, the company maintains research, collaboration, and licensing agreements with Cardiff University and University College Cardiff Consultants Ltd., covering the design, synthesis, characterization, and assessment of these compounds. Further collaborative and licensing arrangements are in place with Cardiff ProTides Ltd. Established in 1997, the company operated as NuCana BioMed Limited before rebranding to NuCana plc in August 2017. Its corporate headquarters are located in Edinburgh, United Kingdom.
Share Price
$1.56
Market Cap
$9.44M
Change (1 day)
-2.20%
Change (1 year)
-58.31%
Country
GB
Trade NuCana plc (NCNA)

Category

Stock price history for NuCana plc (NCNA)
Highest end of day price: $1.46 on 2026-08-01

Lowest end of day price: $86.30K on 2017-09-01
Stock price history of NuCana plc from 2017 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -26.47%
2025 -98.52%
2024 -85.03%
2023 -55.23%
2022 -68.92%
2021 -46.94%
2020 -31.87%
2019 -57.91%
2018 45.00%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$515.58 31.26%
US
$992.01 51.72%
NL
$736.64 7.19%
CH
$1.07K -6.40%
KR
$255.50 13.38%
BE